CELC logo

CELC
Celcuity Inc

1,872
Mkt Cap
$5.43B
Volume
1.95M
52W High
$120.32
52W Low
$7.58
PE Ratio
-31.94
CELC Fundamentals
Price
$114.53
Prev Close
$117.25
Open
$117.17
50D MA
$102.29
Beta
0.94
Avg. Volume
872,407.59
EPS (Annual)
-$2.83
P/B
43.38
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?
Here is how Cabaletta Bio, Inc. (CABA) and Celcuity, Inc. (CELC) have performed compared to their sector so far this year.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Celcuity, Inc. (NASDAQ:CELC) Given Average Recommendation of "Moderate Buy" by Analysts
Celcuity, Inc. (NASDAQ:CELC - Get Free Report) has earned an average rating of "Moderate Buy" from the ten brokerages that are presently covering the stock, MarketBeat.com reports. One research...
MarketBeat·4d ago
News Placeholder
Short Interest in Celcuity, Inc. (NASDAQ:CELC) Expands By 20.9%
Celcuity, Inc. (NASDAQ:CELC - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 8,853,129...
MarketBeat·9d ago
News Placeholder
Nisa Investment Advisors LLC Buys 14,930 Shares of Celcuity, Inc. $CELC
Nisa Investment Advisors LLC lifted its stake in shares of Celcuity, Inc. (NASDAQ:CELC - Free Report) by 2,142.0% in the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·13d ago
News Placeholder
Celcuity (NASDAQ:CELC) Shares Down 6.2% - Should You Sell?
Celcuity (NASDAQ:CELC) Shares Down 6.2% - Here's What Happened...
MarketBeat·13d ago
News Placeholder
Celcuity (NASDAQ:CELC) Reaches New 1-Year High - Still a Buy?
Celcuity (NASDAQ:CELC) Reaches New 12-Month High - Still a Buy...
MarketBeat·14d ago
News Placeholder
Celcuity (NASDAQ:CELC) Shares Gap Down - Here's What Happened
Celcuity (NASDAQ:CELC) Shares Gap Down - Should You Sell...
MarketBeat·16d ago
News Placeholder
Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase?
CELC shares surge as NDA filing and strong phase III data boost optimism around gedatolisib's potential.
Zacks·22d ago
News Placeholder
Celcuity, Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Celcuity, Inc. (NASDAQ:CELC - Get Free Report) have been given a consensus rating of "Moderate Buy" by the ten ratings firms that are presently covering the firm, MarketBeat reports. One...
MarketBeat·29d ago
News Placeholder
Top Biotech Stocks To Add to Your Watchlist - December 20th
Amicus Therapeutics, Vertex Pharmaceuticals, Danaher, United Therapeutics, Moderna, Cidara Therapeutics, and Celcuity are the seven Biotech stocks to watch today, according to MarketBeat's stock...
MarketBeat·1mo ago
<
1
2
...
>

Latest CELC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.